​

Amneal Pharmaceuticals Ownership | Who Owns Amneal Pharmaceuticals?

OverviewForecastRevenueFinancialsChartTranscripts

Amneal Pharmaceuticals Ownership Summary

Amneal Pharmaceuticals is owned by 49.93% institutional investors, 52.18% insiders. Blackrock funding, inc. /de is the largest institutional shareholder, holding 8.08% of AMRX shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 3.29% of its assets in Amneal Pharmaceuticals shares.

AMRX Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockAmneal Pharmaceuticals49.93%52.18%-2.11%
SectorHealthcare Stocks 50.50%12.33%37.17%
IndustrySpecialty & Generic Drug Manufacturers Stocks34.33%15.05%50.62%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de26.56M8.08%$459.79M
Vanguard group17.91M5.70%$225.64M
Tpg gp a12.33M3.75%$213.41M
Blackrock11.28M3.67%$71.64M
Rubric capital management lp10.17M3.09%$176.02M
Vanguard capital management7.71M2.34%$133.46M
State street7.36M2.24%$127.35M
Dimensional fund advisors lp5.79M1.76%$100.30M
Geode capital management5.14M1.56%$88.98M
Morgan stanley4.11M1.25%$71.14M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Westshore wealth1.37M7.34%$23.65M
Tpg gp a12.33M4.27%$213.41M
Tucker asset management1.01M3.71%$12.74M
Quartz partners456.09K2.59%$7.89M
Phocas financial819.48K1.97%$14.19M
Blackbarn capital partners lp1.30M1.90%$22.50M
Rubric capital management lp10.17M1.61%$176.02M
Rpg family wealth advisory377.09K1.35%$6.53M
Nantahala capital management2.27M1.31%$39.27M
Penn capital management company1.18M1.30%$20.48M

Top Buyers

HolderShares% AssetsChange
Sixth street partners management company2.15M0.00%2.15M
Blackrock11.28M0.00%2.12M
Blackrock funding, inc. /de26.56M0.01%2.04M
Congress asset management co /ma782.78K0.08%782.78K
Allspring global investments3.30M0.09%745.96K

Top Sellers

HolderShares% AssetsChange
Fosun---1.72M
Woodline partners lp---1.50M
Hennessy advisors---1.50M
Jain global---1.06M
Jane street group---975.52K

New Positions

HolderShares% AssetsChangeValue
Sixth street partners management company2.15M0.00%2.15M$37.17M
Congress asset management co /ma782.78K0.08%782.78K$13.55M
Panagora asset management443.65K0.02%443.65K$7.68M
Adage capital partners gp272.00K0.01%272.00K$4.71M
Norges bank219.40K0.00%219.40K$3.80M

Sold Out

HolderChange
Twin peaks wealth advisors-3.00
Newedge advisors-5.00
Global financial private client-12.00
Vermillion wealth management-17.00
Wealthspire advisors-24.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2026307-3.46%164,231,0132.72%491.92%182-7.14%858.97%
Mar 31, 202631412.14%158,512,7392.52%502.09%19526.62%77-7.23%
Dec 31, 2025209-16.40%121,259,006-19.77%381.66%107-19.55%65-13.33%
Sep 30, 20252431.25%148,491,3234.94%472.33%131-5.76%7325.86%
Jun 30, 2025235-0.42%141,337,0205.14%452.41%138-2.13%565.66%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
iShares Core S&P Small-Cap ETF10.49M3.29%-7.57K
Vanguard Total Stock Mkt Idx Inv5.56M1.74%4.76K
Vanguard Morn Total Stk Mkt Idx Investor5.56M1.74%4.76K
Vanguard US Total Market Shares ETF4.36M1.39%-
iShares Russell 2000 ETF4.33M1.36%-76.99K
Vanguard Small Cap Index4.02M1.26%45.09K
Vanguard Morn Small Cap Value Index2.56M0.80%-8.15K
Vanguard Small Cap Value Index Inv2.56M0.80%-8.15K
Vanguard Institutional Extnd Mkt Idx Tr1.97M0.62%52.12K
Invesco S&P SmallCap Momentum ETF1.84M0.58%-

Recent Insider Transactions

DateNameRoleActivityValue
Aug 13, 2026Kiely John-Sell$882.00K
Aug 12, 2026Shah Nikita Executive Vice PresidentSell$2.56M
Aug 12, 2026Daly Jason B. EVP, Chief Legal OfficerSell$3.65M
Aug 11, 2026Daly Jason B. EVP, Chief Legal OfficerSell$117.05K
May 11, 2026Autor Deborah M.-Sell$450.56K

Insider Transactions Trends

DateBuySell
2026 Q3-4
2026 Q2-1
2026 Q1--
2025 Q4-2
2025 Q3-11

AMRX Ownership FAQ

Who Owns Amneal Pharmaceuticals?

Amneal Pharmaceuticals shareholders are primarily institutional investors at 49.93%, followed by 52.18% insiders and -2.11% retail investors. The average institutional ownership in Amneal Pharmaceuticals's industry, Specialty & Generic Drug Manufacturers Stocks, is 34.33%, which Amneal Pharmaceuticals exceeds.

Who owns the most shares of Amneal Pharmaceuticals?

Amneal Pharmaceuticals’s largest shareholders are Blackrock funding, inc. /de (26.56M shares, 8.08%), Vanguard group (17.91M shares, 5.70%), and Tpg gp a (12.33M shares, 3.75%). Together, they hold 17.52% of Amneal Pharmaceuticals’s total shares outstanding.

Does Blackrock own Amneal Pharmaceuticals?

Yes, BlackRock owns 3.67% of Amneal Pharmaceuticals, totaling 11.28M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 71.64M$. In the last quarter, BlackRock increased its holdings by 2.12M shares, a 23.11% change.

Who is Amneal Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Westshore wealth is Amneal Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 7.34% of its assets in 1.37M Amneal Pharmaceuticals shares, valued at 23.65M$.

Who is the top mutual fund holder of Amneal Pharmaceuticals shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of Amneal Pharmaceuticals shares, with 3.29% of its total shares outstanding invested in 10.49M Amneal Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools